Abstract:The combination of chemotherapy and photodynamic therapy (PDT) has the potential to complement single-drug therapies, but chemotherapeutic agents and photosensitizers often have compromised ther-apeutic efficacies and strong toxic effects. In this study, we exploited nanotechnology to address this challenge by utilizing heparin as a carrier for co-delivery of chemotherapeutic drugs and photosensitizers for synergistic cancer therapy. Specifically, heparin-paclitaxel (HP-PTX) and heparin-pyropheophorbide-a (HP-Ppa) were synthesized by attaching paclitaxel (PTX), a small molecular chemotherapeutic drug, through a reactive oxygen species (ROS)-responsive linker and Ppa, a photosensitizer, to heparin, respec-tively. Two conjugates were co-assembled into a nanomedicine, HP-PP nanoparticles (NPs), for control-lable co-delivery of Ppa and PTX into tumor cells. HP-PP NPs significantly enhanced the in vitro stability of HP-Ppa and the photostability of Ppa, and the synergistic actions of chemotherapy and PDT were con-firmed by both in vitro and in vivo antitumor studies. Notably, HP-PP NPs enhanced tumor accumulation of Ppa up to 11-fold and the treatment of 4T1 tumor-bearing mice with HP-PP NPs resulted in a tumor growth inhibition of 98.1% without systemic toxicity. The strategy of co-assembly of heparin conjugates may offer great potential in enhancing the efficacy of combination therapy. Statement of significance We proposed a nano-delivery system, HP-PP NPs, which was constructed by co-assembly of heparin-paclitaxel (HP-PTX) and heparin-pyropheophorbide-a (HP-Ppa), to co-deliver PTX and Ppa for synergistic cancer therapy. HP-PP NPs enhanced the photostability and the in vitro stability of Ppa and HP-Ppa, and induced greater cytotoxicity than HP-PTX NPs or HP-Ppa NPs. This co-delivery system displays enhanced tumor accumulation and has a remarkable synergistic antitumor effect with a tumor growth inhibition of 98.1%.& COPY; 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Facile Preparation of Heparin/caco3/cap Hybrid Nano-Carriers with Controllable Size for Anticancer Drug Delivery.

Self-assembled inorganic/organic hybrid nanoparticles with multi-functionalized surfaces for active targeting drug delivery

Peptide decorated calcium phosphate/carboxymethyl chitosan hybrid nanoparticles with improved drug delivery efficiency.

Surface charge-reversible polyelectrolyte complex nanoparticles for hepatoma-targeting delivery of doxorubicin.

Calcium Phosphate Hybrid Nanoparticles: Self-Assembly Formation, Characterization, and Application As an Anticancer Drug Nanocarrier

Calcium Carbonate/Carboxymethyl Chitosan Hybrid Microspheres and Nanospheres for Drug Delivery

Multi‐functional heparin–biotin/heparin/calcium carbonate/calcium phosphate nanoparticles for targeted co‐delivery of gene and drug

Amorphous Calcium Silicate Hydrate/block Copolymer Hybrid Nanoparticles: Synthesis and Application As Drug Carriers

Preparation of Ph-Responsive Hydroxyapatite-Encapsulated Magnetic Fe3O4 Composite Materials with Sandwich Construction for Drug Delivery of Doxorubicin

Designed preparation of polyacrylic acid/calcium carbonate nanoparticles with high doxorubicin payload for liver cancer chemotherapy

The Synthesis and Application of Heparin-Based Smart Drug Carrier

Polymer–Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment

pH-Sensitive N-doped carbon dots–heparin and doxorubicin drug delivery system: preparation and anticancer research

Synthesis and Characterization of Porous CaCO3 Microspheres Templated by Yeast Cells and the Application As Ph Value-Sensitive Anticancer Drug Carrier.

Advanced Nanocarriers Based on Heparin and Its Derivatives for Cancer Management.

Stimuli-responsive Heparin-Drug Conjugates Co-Assembled into Stable Nanomedicines for Cancer Therapy

The Preparation and Morphology Control of Heparin-Based Ph Sensitive Polyion Complexes and Their Application As Drug Carriers.

Natural Polysaccharide-Incorporated Hydroxyapatite As Size-Changeable, Nuclear-Targeted Nanocarrier for Efficient Cancer Therapy

Dendronized Heparin-Doxorubicin Conjugate Based Nanoparticle As Ph-Responsive Drug Delivery System for Cancer Therapy.

Multifunctional Nanoparticles Self-Assembled from Polyethylenimine-Based Graft Polymers As Efficient Anticancer Drug Delivery.

Redox-responsive Nanocarrier Based on Heparin End-Capped Mesoporous Silica Nanoparticles for Targeted Tumor Therapy in Vitro and in Vivo.